HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

LFST

LifeStance Health Group, Inc. (NASDAQ)

Healthcare — Medical Care Facilities

LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a multidisciplinary suite of mental health services, psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It also treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona.

None 10 analysts
$11.43
+$0.72 (+6.72%)
Target: $10.55 (-7.7%)
Sign in to add LFST to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$4.36B
P/E Ratio (TTM)190.50
Forward P/E29.16
EPS (TTM)$0.06
Dividend Yield-
Profit Margin1.55%
Revenue Growth21.20%
ROE1.58%
Debt/Equity32.27
Recommendation None
Analyst Target$10.55
Analysts10
Indexes NASDAQ

Technical Indicators

RSI (14)96.9
Beta1.19
SMA 20-
SMA 40-
52-Week High$11.48
52-Week Low$3.74
50-Day Avg$8.11
200-Day Avg$6.83
Avg Volume$4.52M
Volume$4.95M

Performance Analysis

BEARISH

LFST is flashing more cautionary signals — investors should monitor closely.

- Trading near its 52-week high ($11.48), which may indicate limited upside.
- RSI at 96.9 indicates overbought conditions — a pullback may be due.
+ Price is above both the 50-day and 200-day moving averages — strong uptrend.
- P/E of 190.5 is elevated — the market expects high growth or it may be overvalued.
+ Strong revenue growth of 21.2% year-over-year.
~ Wall Street consensus is "none" from 10 analysts.
- Average analyst target of $10.55 implies 7.7% downside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 02, 2026 13:18 UTC

Back to Screener Export Report